Warning: Undefined array key 1 in /home/ on line 6

A New Revolutionary Insomnia Drug Pends FDA Approval

written by / April 20, 2021
A New Revolutionary Insomnia Drug Pends FDA Approval

This January, the biopharmaceutical company Idorsia Pharmaceuticals Ltd. submitted an application to the Food and Drug Administration (FDA) for the assessment of Daridorexant — the company’s insomnia treatment drug. 

Daridorexant is an absolute novelty in the market because of its effective but short-term action. Specifically, it leaves the patient’s system quickly, enabling them to function without the inconvenient next-day drowsiness caused by other sleep medication

While the traditional insomnia medication is usually a Central Nerve System depressor, Daridorexant is a so-called dual orexin receptor antagonist

This means that it temporarily deactivates the overactive wakefulness by disabling orexin neuropeptides’ action — substances responsible for promoting alertness. 

Today, daytime sleepiness and withdrawal effects are the main reasons why insomniacs reach for the best natural sleep aids instead of prescription pills. But this will change if Daridorexant finds its place on the shelves in pharmacies across the US. 

Namely, during clinical studies, this revolutionary drug showed none of these residual effects

The side effects, the efficacy, and safety of Daridorexant were tested in two clinical trials and a developmental program — all part of the exhaustive New Drug Application (NDA) dossier submitted to the FDA. 

The clinical studies’ results, read publicly in April 2020, revealed that the drug dramatically improves sleep onset, sleep maintenance, and subjective sleep parameters.

Plus, both studies confirm this treatment’s safety for those over 65 years old which is the most insomnia-affected age group. 

Now it is up to the FDA to evaluate this potential game-changer for insomniacs and approve it. If the decision is a positive one, patients will be able to benefit from Daridorexant in the first half of 2022, at the earliest.

Marija Kovachevska is a content writer at, Biochemist and Activist. After obtaining her BSc in Biochemistry and Physiology she changed her microscope for content research tools and continued researching in the fields of Medicine, Biology, and Communication. Her insatiable curiosity flare drove her to become a “content scientist writer” as she likes to say. Reality fascinates her and facts and statistics are a must-have feature in her articles. Fluent in English and French, she is a volunteer and communication associate for several non-profit organizations. French culture and handcrafting are her passion, but in her free time, she indulges in long walks and traveling, or as she likes to say “experiencing the inexperienced.”

Warning: Undefined array key 1 in /home/ on line 6

Warning: Attempt to read property "term_id" on null in /home/ on line 6

Warning: Undefined array key "format" in /home/ on line 23

Warning: Undefined variable $commenter in /home/ on line 27

Warning: Trying to access array offset on value of type null in /home/ on line 27

Warning: Undefined variable $commenter in /home/ on line 29

Warning: Trying to access array offset on value of type null in /home/ on line 29